2020
Resultado de búsqueda
9 de may. de 2024 · The Nobel Prize - Jennifer A. Doudna (May 03, 2024) Jennifer Doudna (born February 19, 1964, Washington, D.C.) is an American biochemist best known for her discovery, with French microbiologist Emmanuelle Charpentier, of a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9.
- Kara Rogers
21 de may. de 2024 · Jennifer Doudna, Nobel Prize Winner. The promise and peril of CRISPR. An intrepid biochemist reckons with the monumental implications of her most provocative discovery to date: a deceptively simple, yet startlingly powerful method to rewrite the very blueprints of life.
- Talks & Ideas > Talks & Ideas, All Ages
- May 21, 2024
Hace 5 días · Ciencia. La ciencia con Alba. La ética de la modificación genética. Gijón acogió la semana pasada el XII Congreso Mundial de Bioética. En él se discutían las implicaciones de la edición génica...
20 de may. de 2024 · Jennifer Doudna’s contributions to science through the development of CRISPR-Cas9 technology have reshaped our understanding of genetics and opened up new possibilities for medicine and beyond. Her journey, marked by a blend of excitement and humility, offers a powerful reminder of the responsibilities that accompany scientific ...
Hace 4 días · Electronic address: doudna@berkeley.edu. PMID: 38781968. DOI: 10.1016/j.cell.2024.04.031. Abstract. Thermostable clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas9) enzymes could improve genome-editing efficiency and delivery due to extended protein lifetimes.
13 de may. de 2024 · No wonder that the inventors of technology, Emmanuelle Charpentier and Jennifer Doudna, have been awarded the Nobel Prize in 2020 . Natural CRISPR/Cas systems are well suited to disrupting coding or non-coding sequences in the genome, are much less effective at distinguishing and editing sequences with single-nucleotide differences ...
12 de may. de 2024 · Key among gene-editing technologies is a molecular tool known as CRISPR-Cas9, a powerful technology discovered in 2012 by American scientist Jennifer Doudna, French scientist Emmanuelle Charpentier, and colleagues and refined by American scientist Feng Zhang and colleagues.
